Image

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Investigational Medication in a Research Study with Immunotherapy and Chemotherapy for Metastatic and Recurrent Pancreatic Adenocarcinoma

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the treatment of metastatic and recurrent pancreatic adenocarcinoma. It explores the use of investigational medication in combination with other therapies.

The purpose of this study is to evaluate the safety and effectiveness of the treatment regimen, focusing on how the combination affects the cancer.

  • Who can participate: Adults aged 18 and older with confirmed pancreatic adenocarcinoma and measurable disease may participate. Key factors include a good performance status and specific blood and organ function levels.
  • Study details: Participants will receive a combination of investigational medication and other treatments. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Metastatic Pancreatic Adenocarcinoma
    Recurrent Pancreatic Adenocarcinoma
    Stage IV Pancreatic Cancer AJCC v8

NCT07226856

Mayo Clinic

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.